15-33739987-C-G

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001036.6(RYR3):​c.7812C>G​(p.Asn2604Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00359 in 1,613,558 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0022 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0037 ( 12 hom. )

Consequence

RYR3
NM_001036.6 missense

Scores

10
8

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4O:1

Conservation

PhyloP100: 0.302

Publications

5 publications found
Variant links:
Genes affected
RYR3 (HGNC:10485): (ryanodine receptor 3) The protein encoded by this gene is a ryanodine receptor, which functions to release calcium from intracellular storage for use in many cellular processes. For example, the encoded protein is involved in skeletal muscle contraction by releasing calcium from the sarcoplasmic reticulum followed by depolarization of T-tubules. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
RYR3 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen, G2P
  • congenital myopathy
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0192343).
BP6
Variant 15-33739987-C-G is Benign according to our data. Variant chr15-33739987-C-G is described in ClinVar as Likely_benign. ClinVar VariationId is 461957.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 3 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RYR3NM_001036.6 linkc.7812C>G p.Asn2604Lys missense_variant Exon 51 of 104 ENST00000634891.2 NP_001027.3 Q15413-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RYR3ENST00000634891.2 linkc.7812C>G p.Asn2604Lys missense_variant Exon 51 of 104 1 NM_001036.6 ENSP00000489262.1 Q15413-1

Frequencies

GnomAD3 genomes
AF:
0.00219
AC:
333
AN:
152166
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000627
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00104
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00426
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00211
AC:
524
AN:
248888
AF XY:
0.00201
show subpopulations
Gnomad AFR exome
AF:
0.000453
Gnomad AMR exome
AF:
0.000290
Gnomad ASJ exome
AF:
0.0000995
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00269
Gnomad NFE exome
AF:
0.00388
Gnomad OTH exome
AF:
0.00166
GnomAD4 exome
AF:
0.00374
AC:
5467
AN:
1461274
Hom.:
12
Cov.:
32
AF XY:
0.00367
AC XY:
2666
AN XY:
726910
show subpopulations
African (AFR)
AF:
0.000598
AC:
20
AN:
33470
American (AMR)
AF:
0.000291
AC:
13
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26122
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86198
European-Finnish (FIN)
AF:
0.00270
AC:
144
AN:
53388
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.00465
AC:
5171
AN:
1111562
Other (OTH)
AF:
0.00195
AC:
118
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.416
Heterozygous variant carriers
0
254
507
761
1014
1268
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
194
388
582
776
970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00219
AC:
333
AN:
152284
Hom.:
3
Cov.:
32
AF XY:
0.00208
AC XY:
155
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.000625
AC:
26
AN:
41568
American (AMR)
AF:
0.000262
AC:
4
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00104
AC:
11
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00426
AC:
290
AN:
68020
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
17
33
50
66
83
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00356
Hom.:
0
Bravo
AF:
0.00187
TwinsUK
AF:
0.00539
AC:
20
ALSPAC
AF:
0.00597
AC:
23
ESP6500AA
AF:
0.000510
AC:
2
ESP6500EA
AF:
0.00505
AC:
42
ExAC
AF:
0.00198
AC:
240
EpiCase
AF:
0.00349
EpiControl
AF:
0.00338

ClinVar

Significance: Likely benign
Submissions summary: Benign:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2Other:1
-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpretted as Uncertain significance and reported on 12/04/2018 by GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -

Nov 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RYR3: BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Epileptic encephalopathy Benign:1
Nov 11, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

RYR3-related disorder Benign:1
Apr 28, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.33
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.22
CADD
Benign
18
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.65
D;.;.;.;.
Eigen
Benign
0.031
Eigen_PC
Benign
0.094
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.85
D;T;D;D;T
M_CAP
Uncertain
0.086
D
MetaRNN
Benign
0.019
T;T;T;T;T
MetaSVM
Uncertain
0.36
D
MutationAssessor
Uncertain
2.6
M;M;.;.;.
PhyloP100
0.30
PrimateAI
Uncertain
0.53
T
PROVEAN
Uncertain
-2.9
.;D;.;.;.
REVEL
Uncertain
0.42
Sift
Uncertain
0.0040
.;D;.;.;.
Polyphen
0.36
B;B;.;.;.
Vest4
0.62
MutPred
0.67
Gain of ubiquitination at N2604 (P = 0.0117);Gain of ubiquitination at N2604 (P = 0.0117);.;Gain of ubiquitination at N2604 (P = 0.0117);.;
MVP
0.93
MPC
0.34
ClinPred
0.042
T
GERP RS
3.5
Varity_R
0.65
gMVP
0.39
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41279214; hg19: chr15-34032188; API